Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr;64(4):685-692.
doi: 10.1111/trf.17797. Epub 2024 Mar 20.

Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease

Kai Rogers  1 , Mouaz Alsawas  1 , James Chapman  1 , Annette J Schlueter  1 , Charles Michael Knudson  1
Affiliations
Review

Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease

Kai Rogers et al. Transfusion. 2024 Apr.

Abstract

Background: Red blood cell exchange is often used prophylactically in patients with sickle cell disease, with the goal to maintain hemoglobin S (HbS) below a target threshold level. We reviewed whether the daily "rate of rise" (RoR) in HbS that occurs between procedures can be used for patient management. For some patients not achieving their HbS goals despite efficient exchanges, the post-procedure hematocrit (Hct) target is increased to potentially suppress HbS production. This case series explores the utility of this approach, other clinical uses of the daily RoR in HbS, and the factors that influence it.

Study design and methods: A total of 660 procedures from 24 patients undergoing prophylactic RBC depletion/exchange procedures were included. Laboratory values and clinical parameters were collected and used to calculate the daily RoR in HbS. Factors such as Hct or medications that might influence the RoR in HbS were evaluated.

Results: The RoR in HbS varied widely between patients but remained relatively stable within individuals. Surprisingly, this value was not significantly influenced by changes in post-procedure Hct or concurrent hydroxyurea use. A patient's average RoR in HbS effectively predicted the pre-procedure HbS at the following visit (R2 = 0.65).

Discussion: The RoR in HbS is a relatively consistent parameter for individual patients that is unaffected by medication use or procedural Hct targets and may be useful in determining intervals between procedures.

Keywords: hemoglobinopathy; red cell depletion/exchange; sickle cell disease.

PubMed Disclaimer

References

REFERENCES

    1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512–S521.
    1. Lee L, Smith‐Whitley K, Banks S, Puckrein G. Reducing health care disparities in sickle cell disease: a review. Public Health Rep. 2019;134(6):599–607.
    1. Ingram VM. A specific chemical difference between the globins of normal human and sickle‐cell anaemia haemoglobin. Nature. 1956;178(4537):792–794.
    1. Chen G, Zhang D, Fuchs TA, Manwani D, Wagner DD, Frenette PS. Heme‐induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. Blood. 2014;123(24):3818–3827.
    1. Lard LR, Mul FP, de Haas M, Roos D, Duits AJ. Neutrophil activation in sickle cell disease. J Leukoc Biol. 1999;66(3):411–415.

Substances

LinkOut - more resources